Tag: R&D

Research and development (R&D or R+D), also known in Europe as research and technical (or technological) development (RTD), is a general term for activities in connection with corporate or governmental innovation. Research and development is situated at the front end of the innovation life cycle, which may end with commercialization.

Chinese researchers made progress in development of Alzheimer’s disease drug

alzheimer's disease
GV-971 was developed by Ocean University of China, Shanghai Institute of Materia Medica under Chinese Academy of Sciences and Green Valley Pharmaceutical.

Scientist.com partnered with HealthEconomics.Com to connect RWE researchers

lab
The partnership between Scientist.com and HealthEconomics.Com will provide an effective method to connect RWE researchers with service providers to simplify the research sourcing process and enhance market access.

Alpha Genesis Primate Research Center to expand its European capabilities

microscope
The Alpha Genesis Primate Research Center, the Research Division of Alpha Genesis Incorporated, is to take on additional European business commitments as the firm continues its expansion efforts on the continent.

MedImmune and 4D Molecular Therapeutics to collaborate on AAV gene therapy

gene-therapy
MedImmune, the global biologics research and development arm of AstraZeneca, and 4D Molecular Therapeutics announced a collaboration to develop and commercialize a gene therapeutic for patients with chronic lung disease.

Russian scientists created an antibacterial coating for hospitals

inh-so-ran
Researchers at the Institute of Inorganic Chemistry of Siberian Branch of the Russian Academy of Sciences proposed to use cluster complexes of tungsten and molybdenum as photoactive components in antibacterial materials.

Selexis and Symphogen expand their R&D partnership

drug-development
Selexis announced that under the terms of an earlier commercial license agreement, Symphogen has opened two investigational new drug applications for clinical programs utilizing Selexis Genetic Elements.

UK government launches AMR research competition

Antimicrobial resistance
The Department of Health and Social Care (UK) is announcing the launch of a £10 million (approximately €11,3 million) research competition to fund innovations to tackle antimicrobial resistance in humans.

The University of Hong Kong founded a new biotech innovation platform

biotech
The University of Hong Kong (HKU) announced it had established a biotechnology innovation platform in Zhongshan (Guangdong province, China).

Recent study on herpes virus could lead to the development of new drugs

herpes-virus
Researchers at the University of Glasgow used the cutting-edge technique to reveal, in high resolution, the biological mechanisms the herpes virus uses to infect people.

Cleara Biotech advances in the development of new therapeutics

pre-clinical
Cleara Biotech B.V., a Netherlands-based biopharmaceutical company, announced the creation of three public-private partnerships to discover and develop new therapeutics.

Jennewein Biotechnologie will set up a new R&D Center in Bonn

biotechnologies
Jennewein Biotechnologie, a German science-based company, has signed a rental contract of long duration for a space with 1000 sq m in the Mildred-Scheel-Straße in Bonn-Bad Godesberg.

Cellect entered into stem cell collaboration with denovoMATRIX

stem-cell
Cellect Biotechnology, an Israeli developer of a novel stem cell production technology, signed a collaboration and material transfer agreement with the denovoMATRIX group of the Technische Universität Dresden.

Enzyvant starts partnership with Visikol

research
Enzyvant, a biopharmaceutical company, formed a partnership with Visikol, a contract research organization focused on digital pathology and drug discovery.

Seqirus joined the Universal Influenza Vaccine Initiative

influenza vaccine
The Human Vaccines Project, a nonprofit public-private partnership, and Seqirus, a global leader in the prevention of influenza, announced that Seqirus is joining the Project's Universal Influenza Vaccine Initiative.

Sanofi sets up its Global R&D Operations Hub in China

sanofi-china
Sanofi is launching a Global R&D Operations Hub with a specialized focus on digitalization and big data analysis in Chengdu, Sichuan province, China.

Boston College researchers made a step towards targeted antibiotics

microbe
The approach of Boston College scientists maps, ranks, and identifies where antibiotic sensitivity functions reside in the genome of strains of S. pneumoniae.